Accumulation of low-avidity anti-melanocortin receptor 1 (anti-MC1R) CD8+ T cells in the lesional skin of a patient with melanoma-related depigmentation
- 1 April 2006
- journal article
- case report
- Published by Wolters Kluwer Health in Melanoma Research
- Vol. 16 (2) , 165-174
- https://doi.org/10.1097/01.cmr.0000198452.03957.73
Abstract
Spontaneous or therapy-induced depigmentation in patients with melanoma has long been considered a favourable prognostic indicator. In this report, we isolated T cells infiltrating the depigmented skin of an HLA-A2+/DR4+ patient with melanoma, and detected a very high frequency of CD8+ T cells specific for melanocortin receptor 1 (MC1R), a hormone receptor involved in cutaneous pigmentation. In particular, tissue-infiltrating CD8+ T cells dominantly recognized the novel MC1R52-60 peptide epitope in an HLA-A2-restricted manner, and peptide-reactive CD8+ T cells were also detected in freshly isolated peripheral blood from this patient. Although type 1 CD4+ T-cell responses against MC1R were not detected in fresh tissue isolates, short-term in-vitro stimulation of peripheral blood lymphocytes resulted in the rapid expansion of CD4+ T cells reactive against novel HLA-DR4-presented epitopes derived from the MC1R protein (i.e. MC1R82-95, MC1R105-118 and MC1R149-161). MC1R peptide-specific CD8+ T-cell clones isolated from the depigmented skin of this patient were characterized by comparatively low functional avidity for specific major histocompatibility complex-peptide complexes and were poorly lytic; however, these effector cells were capable of secreting both interferon-gamma and granzyme B against relevant target cells in vitro, and may have played an important role in the induction of leucoderma in situ in this patienKeywords
This publication has 27 references indexed in Scilit:
- Molecular and Functional Bases of Self-Antigen Recognition in Long-Term Persistent Melanocyte-Specific CD8+ T Cells in One Vitiligo PatientJournal of Investigative Dermatology, 2003
- Melanocyte-Specific Immune Response in Melanoma and Vitiligo: Two Faces of the Same Coin?Pigment Cell Research, 2003
- Skin colour and skin cancer –MC1R, the genetic linkMelanoma Research, 2002
- Melanocortin 1 Receptor (MC1R) Gene Variants are Associated with an Increased Risk for Cutaneous Melanoma Which is Largely Independent of Skin Type and Hair ColorJournal of Investigative Dermatology, 2001
- Local Immune Response in Skin of Generalized Vitiligo PatientsLaboratory Investigation, 2000
- α‐MSH and the Regulation of Melanocyte FunctionAnnals of the New York Academy of Sciences, 1999
- A peptide encoded by human gene MAGE‐3 and presented by HLA‐A2 induces cytolytic T lymphocytes that recognize tumor cells expressing MAGE‐3European Journal of Immunology, 1994
- Tumor immunity as autoimmunity: tumor antigens include normal self proteins which stimulate anergic peripheral T cellsImmunology Today, 1993
- Prolonged survival in metastatic malignant melanoma associated with vitiligoClinical and Experimental Dermatology, 1991
- Vitiligo in patients with metastatic melanoma: A good prognostic signJournal of the American Academy of Dermatology, 1983